Results 141 to 150 of about 61,606 (299)

Level of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in Jos, North-Central Nigeria

, 2021
Akinyemi O D Ofakunrin, Edache S. Okpe, Tolulope Afolaranmi, Rasaq Olaosebikan, Patience Ungut Kanhu, Kehinde Adekola, Nantok Dami, Atiene S. Sagay   +7 more
openalex   +2 more sources

Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease [PDF]

, 2023
Maite E. Houwing, Jennifer Bos, Richard van Wijk, Eduard J. van Beers, Marjon H. Cnossen, Minke A.E. Rab   +5 more
openalex   +1 more source

Radioiodination of Two Carborane‐Based Dual Cyclooxygenase‐2/5‐Lipoxygenase Inhibitors and Their In Vitro and In Vivo Evaluation

ChemBioChem, Volume 27, Issue 7, 14 April 2026.
Two dicarbadodecaborane(12)‐based dual cyclooxygenase‐2/5‐lipoxygenase (COX‐2/5‐LO) inhibitors were 123I‐labeled. Refinement of labeling and formulation conditions and extensive in vitro characterization are presented. Cell uptake studies in COX‐2‐ and 5‐LO‐overexpressing cell lines showed COX‐2‐independent and partly 5‐LO‐dependent uptake.
Jonas Schädlich, Martin Ullrich, Cathleen Haase‐Kohn, Robert Wodtke, Sebastian Braun, Maximilian Molitor, Bettina Hofmann, Dieter Steinhilber, Klaus Kopka, Evamarie Hey‐Hawkins, Jens Pietzsch, Markus Laube   +11 more
wiley   +1 more source

Early detection and management of extracranial arteriopathy reduces the incidence of silent cerebral infarcts in sickle cell anemia: a long-term prospective cohort study

Haematologica
Previous reports about the Creteil newborn-cohort (1988/Apr-2007) showed that the risk of silent cerebral infarcts (SCI) remained high (37.1%) by age 14 in children with sickle cell anemia (SCA) and intracranial time-averaged mean maximum velocity ...
Francoise Bernaudin, Cecile Arnaud, Annie Kamdem, Jenny Youn, Manuela Vasile, Isabelle Hau, Fouad Madhi, Aline Malterre, Celine Delestrain, Ralph Epaud, Camille Jung, Suzanne Verlhac   +11 more
doaj   +1 more source

Hydroxyurea-induced melanonychia

JAAD Case Reports, 2023
Michael G. Buontempo, BS, Zaima S. Chaudhry, MD, Ruchi S. Raval, BS, Kelly Mourtzanakis, BS, Vignesh Ramachandran, MD, Jerry Shapiro, MD, Kristen Lo Sicco, MD   +6 more
openaire   +3 more sources

Impact of the 2014 NHLBI Hydroxyurea Guidelines on Cerebrovascular Events in Sickle Cell Disease [PDF]

, 2023
Aleksandra S. Dain, Yimei Li, Sahal Master, Shri Karthikeyan, Leslie Raffini, Kelly Getz, Janet L. Kwiatkowski   +6 more
openalex   +1 more source

Hydroxyurea

Journal of Biological Chemistry, 1967
Roger L.P. Adams, J.G. Lindsay
openaire   +1 more source

Clinical methemoglobinemia secondary to administration of hydroxyurea at therapeutic doses in a dog

Journal of Veterinary Internal Medicine
Methemoglobinemia secondary to administration of hydroxyurea is only reported in veterinary medicine as a result of accidental ingestion of high doses, and once at therapeutic dose in human medicine.
Manon Rigot, Shane W. Bateman, Xiu Ting Yiew   +2 more
doaj   +1 more source

Protective potential of royal jelly against hydroxyurea -induced hepatic injury in rats via antioxidant, anti-inflammatory, and anti-apoptosis properties

, 2022
Hossam G. Tohamy, Mahmoud S. El‐Neweshy, Mohamed Mohamed Soliman, Samy Sayed, Mustafa Shukry, Heba I. Ghamry, Hoda A. Abd-Ellatieff   +6 more
openalex   +2 more sources

Hydroxyurea therapy in UK children with sickle cell anaemia: A single‐centre experience [PDF]

, 2017
K. L. E. Phillips, Laura Healy, Louise Smith, Russell Keenan   +3 more
openalex   +1 more source